CD274 and breast carcinoma: Disrupting PD-L1 palmitoylation by site-specific point mutation or inhibiting the expression of its PAT ZDHHC9 sensitized breast cancer cells to T-cell killing and thus repressed tumor growth.296 Another group formulated the same conclusion with more details in CRC.